https://www.selleckchem.com/pr....oducts/Cisplatin.htm
itive measure than plasma NfL to monitor disease progression. This preHD cohort is one of the earliest yet studied, and our findings could be used to inform decisions about when to initiate a potential future intervention to delay or prevent further neurodegeneration while function is intact. Funding Wellcome Trust, CHDI Foundation.Background Deep brain stimulation (DBS) of the subthalamic nucleus is an established therapeutic option for managing motor symptoms of Parkinson's disease. We conducted a double-blind, sham-controlled, rand
Beğen
Yorum Yap
Paylaş
